Vinay Prasad, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), ...

GSK (LSE: GSK) has chosen to unwind its synthetic lethality alliance with US biotech Ideaya Biosciences (Nasdaq: IDYA), ...

Florida-based cell therapy company Gamida Cell has won US approval for Omisirge (omidubicel-onlv), the first hematopoietic ...

Sanegene Bio has raised more than $110 million in a series B round to move its RNAi programs toward registration studies and ...

China is making significant strides in CAR-T innovation. Recently, Chongqing Precision Biotech received approval for Priligy ...

The European Commission has approved Roche’s Gazyva/Gazyvaro (obinutuzumab) in combination with mycophenolate mofetil (MMF) ...

Italian pharma major Recordati’s rare diseases subsidiary announced the presentation of new data detailing advances in the ...

The cell and gene therapy (CGT) sector is undergoing a transition as companies navigate a more selective and strategy-driven ...

Roche (ROG: SIX) has unveiled a fresh wave of data for Lunsumio (mosunetuzumab), underscoring the Swiss pharma major’s ...

Kallyope is preparing to move its oral migraine candidate elismetrep toward registrational development after the TRPM8 ...

Ascletis Pharma (HKEX: 1672) has reported positive topline results from a 13-week Phase II study of ASC30, its once-daily oral GLP-1 agonist for obesity. All three doses met the primary endpoint with ...

The US Association for Accessible Medicines (AAM) the leading trade association for generic and biosimilar manufacturers, applauds and supports The Skinny Labels, Big Savings Act, which was introduced ...